Loading stock data…
West Pharmaceutical Services, I (WST)
$337.75-2.22 (-0.65%)
Market ClosedLast close Sep 8
West Pharmaceutical Services, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
West Pharmaceutical Services, Inc. in the Healthcare sector is trading at $337.75 with a market capitalization of $23.8B. Wall Street consensus targets $404.73 (15 analysts), implying a +19.8% move over the next 12 months. The stock is currently 12% below its 52-week high of $386.00, remaining 15.0% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +19.8% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $872.30M↑ | $844.90M↑ | $805.00M | $804.60M↑ | $766.50M |
| Gross Profit | $329.20M↑ | $296.40M↓ | $303.90M↑ | $294.30M↑ | $273.90M |
| Operating Income | $191.90M↑ | $181.10M↑ | $175.10M↑ | $174.50M↑ | $158.90M |
| Net Income | $154.00M↑ | $138.80M↑ | $132.10M↓ | $140.00M↑ | $131.80M |
Peer Comparison
JNJUNHPFE
Fundamentals
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Pro...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$23.82B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
43.39
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.16
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.26%
ROE
Elite ROE. Management converts capital into profit efficiently.
18.89%
Volume
Today's trading volume
570,603
Recent News
Philips Expands Women's Health Ultrasound Portfolio With New Transducer
PHG broadens women's health ultrasound portfolio with the eV14-2v, offering enhanced imaging, a lighter design and remote collaboration.
Novocure Reports Patient Data Exposure in Cybersecurity Incident
NVCR says a cyber incident exposed limited patient and contact data, but devices stayed secure and operations remained fully functional.
Do You Believe West Pharmaceutical Services (WST) Represents a Tremendous Opportunity?
Generation Investment Management, an investment management firm, released its “Global Equity Strategy” second quarter 2026 investor letter. The letter can be downloaded here. The letter discusses the challenges of AI-driven market concentration and emphasizes the potential for long-term investors. It notes that the best companies are currently underperforming due to market returns being concentrated in […]
West Pharmaceutical Services (WST) And The GLP 1 Story Behind Its Fair Value Gap
How West Pharmaceutical Services stock has been performing West Pharmaceutical Services (WST) has drawn investor attention after recent share price moves, with the stock closing at US$339.97 on 3 September 2026. The company shows mixed returns over different periods, including gains over the past year alongside shorter term pullbacks. For West Pharmaceutical Services, the recent 1-day share price decline of 0.81% and 3.15% share price pullback over 30 days sit against a much stronger...
Here's Why You Should Retain Cencora Stock in Your Portfolio for Now
Cencora's specialty momentum, OneOncology growth and GLP-1 volumes offer upside, but drug-price cuts and MWI risks cloud its outlook.